Skip Navigation
Wilmer Eye Institute
Print This Page
Share this page: More

Endophthalmitis Post Cataract Surgery Study

EPCS LogoEndophthalmitis Post Cataract Surgery Study (EPCS)

The EPCS study is a nationwide study being conducted to evaluate risk factors for endophthalmitis following cataract surgery. The objectives of the study are:

  1. To ascertain the rates of endophthalmitis after cataract surgery on a national level in the United States, and
  2. To identify risk factors for the development of endophthalmitis.

The second objective will be achieved through a case control study. The study relies on the Medicare claims database to identify patients who had cataract surgery in 2003 and 2004 and subsequently had a diagnosis of endophthalmitis within six weeks after surgery (cases). 700 cases of presumed endophthalmitis have been selected. In addition, we have also randomly selected approximately 3,500 cataract surgeries after which no endophthalmitis claims were submitted (controls).

Once cataract surgery cases have been identified, the surgery provider will be contacted to request information on the specifics of the surgery, including such things as cataract wound size and location, perioperative antibiotic use and information about the patient such as presence of systemic disease (e.g. diabetes).

Physicians who provided treatment for endophthalmitis will also be contacted to obtain information on the diagnosis and treatment.

No data obtained in this study will be given to Medicare, and in no way will any participating surgeon be identified individually. All data are completely confidential, and results will only be reported at an aggregate level.

This study complies with national HIPAA regulations and has received IRB approval from the Johns Hopkins Medical Institutions IRB. This approval extends to individual physician's participation in the study (links to documentation provided below).

Please send all correspondence to:

Dr. Emily Gower, or Dr. Lisa Keay
600 N. Wolfe Street / Wilmer 116
Baltimore, MD 21287
Phone: (410) 614-5636
Fax: (888) 681-0979

Dr. Sheila West on the Link Between Smoking and Eye Disease in Women - 7/23/2014

Dr. Pradeep Ramulu and Colleagues Study Relationship Between Vision Loss and Work Status - 7/18/2014

Wilmer Resident Receives Lindstrom Research Grant - 7/11/2014

Four Wilmer Researchers Receive BrightFocus Foundation Awards - 7/10/2014

Dr. Michael Repka Part of Team Researching Telemedicine and ROP - 6/27/2014

Dr. M. Valeria Canto-Soler and Colleagues Featured on WBAL-TV - 6/24/2014

Dr. M. Valeria Canto-Soler and Colleagues Use Human Stem Cells to Create Light-Sensitive Retina in a Dish - 6/10/2014

Wilmer's Division of Ocular Immunology Announces "Living With Uveitis" Support Group - 6/10/2014

Dr. Neil Bressler to Speak on Diabetic Retinopathy at National Eye Health Summit and Webcast - 6/10/2014

Dr. Donald Zack Receives a Research to Prevent Blindness Nelson Trust Award for Retinitis Pigmentosa - 6/9/2014

Dr. Michael Boland Leads Study on Effectiveness of Automated Telecommunication-Based Reminders on Adherence to Glaucoma Medication Dosing - 6/4/2014

Dr. Christina Prescott Discusses Summer Eye Protection on Fox 45 News - 6/1/2014

Dr. Jonathan Song Discusses Treatment Options for Pediatric Cataracts - 5/23/2014

Johns Hopkins' Jordan Green Discusses His Work at Wilmer's Translational Tissue Engineering Center - 5/21/2014

Longtime Wilmer Employee Lillie Alston Honored by Hopkins - 5/19/2014

Dr. Richard Semba: Diets Rich in Antioxidant Resveratrol Fail to Reduce Deaths, Heart Disease or Cancer - 5/12/2014

Dr. Neil Miller Explains Eye Twitching in The Wall Street Journal - 5/12/2014

Dr. Hendrik Scholl Receives ARVO Award - 5/7/2014


Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer